MediPharm Labs Updates Shareholders on Meeting Status and Vision

MediPharm Labs Addresses Shareholders as Meeting Approaches

MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ), a leader in precision-based cannabinoid products, is reaching out to its valued shareholders regarding recent communications from Apollo Technology Capital Corporation. These communications have prematurely characterized the results of the upcoming annual and special meeting of shareholders as a victory for Apollo. It’s important for our shareholders to understand that the meeting, scheduled for 3:00 p.m., is yet to occur, and therefore, no results are available.

MediPharm is committed to maintaining transparency. Once the meeting concludes, we will provide the final results in accordance with regulatory requirements and Toronto Stock Exchange rules. This commitment reflects our dedication to upholding the trust of our shareholders.

About MediPharm Labs: A Leader in Cannabis Concentrates

Founded in 2015, MediPharm Labs has positioned itself as a pioneer in the pharmaceutical-grade cannabis concentrate industry. Our focus is on developing and manufacturing purified cannabis products with stringent quality controls. Our facilities are compliant with Good Manufacturing Practices (GMP) standards, ensuring that we deliver reliable, high-quality cannabinoid-based products.

With a state-of-the-art manufacturing setup, we continually invest in innovative purification technologies and a highly skilled research team. This investment allows us to produce precision-dosed cannabis products tailored to our customer's needs, both in domestic and international medical markets.

Significant Achievements and Licenses

In our journey, a significant milestone was achieved when we received a Pharmaceutical Drug Establishment License from Health Canada in 2021. This made us the first company in North America with a commercial-scale GMP license for multiple natural cannabinoids extraction. This recognition has been paramount as we pursue FDA registration for foreign drug manufacturing, paving the way for our international operations.

Expansion Through Strategic Acquisitions

The landscape of our business expanded significantly in 2023 when we acquired VIVO Cannabis Inc. This strategic acquisition allowed us to extend our medical services through Canna Farms, enhancing our reach in Canada and entering new markets in Australia and Germany. Furthermore, we integrated Harvest Medical Clinics, which focuses on connecting medical cannabis patients with physicians for consultations, educational resources, and prescriptions.

Commitment to Compliance and Quality

MediPharm Labs operates under a framework of stringent compliance with laws applicable in every country where we operate. This commitment not only upholds our integrity but also reinforces our mission to deliver safe and effective cannabinoid products.

Contacting MediPharm Labs

For any investor-related inquiries, shareholders can reach out to MediPharm Labs Investor Relations at:

Telephone: +1 416.913.7425
Email: investors@medipharmlabs.com

For media inquiries, please contact:

John Vincic
+1 (647) 402-6375
Email: john@oakstrom.com

Frequently Asked Questions

What is the purpose of the MediPharm Labs meeting?

The meeting is to discuss important company matters and update shareholders on progress and plans.

What is MediPharm Labs known for?

MediPharm Labs specializes in precision-based cannabinoid products, focusing on quality and compliance in cannabis manufacturing.

How have recent acquisitions benefited MediPharm Labs?

The acquisition of VIVO Cannabis Inc. allowed for expansion into new markets and enhanced medical services for patients.

What regulatory approvals does MediPharm Labs hold?

MediPharm holds GMP licenses and a Pharmaceutical Drug Establishment License from Health Canada, essential for its operations.

How can investors contact MediPharm Labs?

Investors can reach MediPharm Labs through their Investor Relations email or by phone listed above.

About The Author

Greetings, I'm 32-year-old author and financial specialist Evelyn Baker. My introduction into the financial industry started with an economics degree and continued with a wealth of experience in wealth management and financial consulting. My great passion over the years has been assisting people and companies in making wise, well-informed decisions to reach their financial objectives.

My goal with writing is to simplify difficult financial ideas into understandable, doable guidance. My goal in writing many books and articles is to make personal finance understandable to everyone, irrespective of their experience or background. I want to give readers the information they need to take charge of their financial futures, from investing and retirement planning to budgeting and saving.

Along with my writing, I lead webinars and workshops where I provide doable advice and methods for achieving financial success. To reach a larger audience, I also frequently contribute to financial blogs and publications. My method is always to offer doable, real-world guidance that can actually improve people's lives.

Aside from my job, I like to cook, travel, and experience other cultures. I work hard to apply my belief in the value of a balanced life to my financial counsel. My goal in working is to encourage and enable people to succeed financially so they may lead the best lives possible.

Contact Evelyn Baker privately here. Or send an email with ATTN: Evelyn Baker as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.